⌘K
Loading ticker…
As of 2026-08-24, Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) has a 3-month relative strength percentile of 98 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 75. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.0%, relative volume 2.41×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ARCT is held by 19 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $3M.
Held by 39 ETFs · $48M across latest filings · largest weight 1.96% (ARKG).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $1M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.00% | $1M | — |
| VHTVanguard Health Care ETF | 0.00% | $618K | — |
| AVSC | 0.02% | $450K | — |
| SBIO | 0.14% | $232K | — |
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $206K |
| new |
| GSSC | 0.01% | $103K | — |
| VTWV | 0.01% | $100K | — |
| VTWG | 0.00% | $75K | — |
| AVUSAvantis U.S. Equity ETF | 0.00% | $53K | — |
Showing 10 of 19 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARCT Jan avg: 12.75% median: 13.21% win: 75% σ: 12.28% n: 4 2022-04-12 → 2026-07-31 | ARCT Feb avg: 0.90% median: 4.56% win: 50% σ: 17.73% n: 4 2022-04-12 → 2026-07-31 | ARCT Mar avg: -2.12% median: -9.54% win: 25% σ: 35.62% n: 4 2022-04-12 → 2026-07-31 | ARCT Apr avg: -1.17% median: 11.05% win: 60% σ: 21.89% n: 5 2022-04-12 → 2026-07-31 | ARCT May avg: 9.35% median: 2.58% win: 60% σ: 24.13% n: 5 2022-04-12 → 2026-07-31 | ARCT Jun avg: -12.90% median: -15.15% win: 40% σ: 17.73% n: 5 2022-04-12 → 2026-07-31 | ARCT Jul avg: 1.86% median: -3.65% win: 40% σ: 14.57% n: 5 2022-04-12 → 2026-07-31 | ARCT Aug avg: -0.98% median: -11.62% win: 25% σ: 27.18% n: 4 2022-04-12 → 2026-07-31 (current) | ARCT Sep avg: 2.02% median: 6.95% win: 75% σ: 12.03% n: 4 2022-04-12 → 2026-07-31 | ARCT Oct avg: -18.83% median: -24.43% win: 25% σ: 27.45% n: 4 2022-04-12 → 2026-07-31 | ARCT Nov avg: 0.27% median: 3.81% win: 75% σ: 23.72% n: 4 2022-04-12 → 2026-07-31 | ARCT Dec avg: 1.62% median: -7.75% win: 25% σ: 20.08% n: 4 2022-04-12 → 2026-07-31 |